These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35681579)

  • 1. Intensity-Modulated Radiotherapy (IMRT) following Conservative Surgery of the Supraglottic Region: Impact on Functional Outcomes.
    Alterio D; Marani S; Zurlo V; Zorzi SF; Ferrari A; Volpe S; Bandi F; Vigorito S; Vincini MG; Gandini S; Gaeta A; Fodor CI; Casbarra A; Zaffaroni M; Starzyńska A; Belgioia L; Ansarin M; Aristei C; Jereczek-Fossa BA
    Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transitioning from conformal radiotherapy to intensity-modulated radiotherapy after radical prostatectomy: Clinical benefit, oncologic outcomes and incidence of gastrointestinal and urinary toxicities.
    Flores-Balcázar CH; Urías-Arce DM; Bourlon MT; Gabilondo-Navarro F; Pérez-Álvarez SI; Ramos-Prudencio R; Rodríguez-Covarrubias F
    Rep Pract Oncol Radiother; 2020; 25(4):568-573. PubMed ID: 32494230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity Profile of IMRT Vs. 3D-CRT in Head and Neck Cancer: A Retrospective Study.
    Ghosh G; Tallari R; Malviya A
    J Clin Diagn Res; 2016 Sep; 10(9):XC01-XC03. PubMed ID: 27790562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric and clinical toxicity comparison of critical organ preservation with three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, and RapidArc for the treatment of locally advanced cancer of the pancreatic head.
    Jin L; Wang R; Jiang S; Yue J; Liu T; Dou X; Zhu K; Feng R; Xu X; Chen D; Yin Y
    Curr Oncol; 2016 Feb; 23(1):e41-8. PubMed ID: 26966412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical study of intensity modulated radiotherapy and three-dimensional conformal radiotherapy with three-dimensional brachytherapy and concurrent chemotherapy for patients with advanced cervical cancer].
    Du XX; Yang H; Zhang HJ; Li LA; Fan WS; Meng YG
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):679-686. PubMed ID: 29060966
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison three-dimensional conformal radiotherapy versus intensity modulated radiation therapy in local control of head and neck cancer.
    Ghosh G; Gupta G; Malviya A; Saroj D
    J Cancer Res Ther; 2018; 14(6):1412-1417. PubMed ID: 30488865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prone hypofractionated whole-breast radiotherapy without a boost to the tumor bed: comparable toxicity of IMRT versus a 3D conformal technique.
    Hardee ME; Raza S; Becker SJ; Jozsef G; Lymberis SC; Hochman T; Goldberg JD; DeWyngaert KJ; Formenti SC
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e415-23. PubMed ID: 22019349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation dose escalation for localized prostate cancer: intensity-modulated radiotherapy versus permanent transperineal brachytherapy.
    Wong WW; Vora SA; Schild SE; Ezzell GA; Andrews PE; Ferrigni RG; Swanson SK
    Cancer; 2009 Dec; 115(23):5596-606. PubMed ID: 19670452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensity-Modulated Radiotherapy versus Three-Dimensional Conformal Radiotherapy in Definitive Chemoradiotherapy for Cervical Esophageal Squamous Cell Carcinoma: Comparison of Survival Outcomes and Toxicities.
    Chen NB; Qiu B; Zhang J; Qiang MY; Zhu YJ; Wang B; Guo JY; Cai LZ; Huang SM; Liu MZ; Li Q; Hu YH; Li QW; Liu H
    Cancer Res Treat; 2020 Jan; 52(1):31-40. PubMed ID: 31048664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric evaluation of 3-D conformal and intensity-modulated radiotherapy for breast cancer after conservative surgery.
    Mansouri S; Naim A; Glaria L; Marsiglia H
    Asian Pac J Cancer Prev; 2014; 15(11):4727-32. PubMed ID: 24969911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of the application among intensity-modulated radiotherapy, 3D-conformal radiotherapy and conventional radiotherapy for locally advanced middle-low rectal cancer].
    Zhang C; Dong J; Shen T; Li Y; Yang Z; Cheng X; Luo H; Yang J; Shi Z; Wang W; Zhang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Dec; 21(12):1414-1420. PubMed ID: 30588595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric comparison of helical tomotherapy, intensity-modulated radiation therapy, volumetric-modulated arc therapy, and 3-dimensional conformal therapy for the treatment of T1N0 glottic cancer.
    Ekici K; Pepele EK; Yaprak B; Temelli O; Eraslan AF; Kucuk N; Altınok AY; Sut PA; Alpak OD; Colak C; Mayadagli A
    Med Dosim; 2016 Winter; 41(4):329-333. PubMed ID: 27765542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 3D confromal radiotherapy and intensity modulated radiotherapy with or without simultaneous integrated boost during concurrent chemoradiation for locally advanced head and neck cancers.
    Spiotto MT; Weichselbaum RR
    PLoS One; 2014; 9(4):e94456. PubMed ID: 24714187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment-related toxicity in men who received Intensity-modulated versus 3D-conformal radiotherapy after radical prostatectomy: A national population-based study.
    Sujenthiran A; Nossiter J; Parry M; Charman SC; Cathcart PJ; van der Meulen J; Clarke NW; Payne H; Aggarwal A
    Radiother Oncol; 2018 Aug; 128(2):357-363. PubMed ID: 29773442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy.
    Ashman JB; Zelefsky MJ; Hunt MS; Leibel SA; Fuks Z
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):765-71. PubMed ID: 15913914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy as adjuvant therapy for gastric cancer.
    Minn AY; Hsu A; La T; Kunz P; Fisher GA; Ford JM; Norton JA; Visser B; Goodman KA; Koong AC; Chang DT
    Cancer; 2010 Aug; 116(16):3943-52. PubMed ID: 20564136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing morbidity and cancer control after 3D-conformal (70/74 Gy) and intensity modulated radiotherapy (78/82 Gy) for prostate cancer.
    Dolezel M; Odrazka K; Zouhar M; Vaculikova M; Sefrova J; Jansa J; Paluska P; Kohlova T; Vanasek J; Kovarik J
    Strahlenther Onkol; 2015 Apr; 191(4):338-46. PubMed ID: 25589224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy.
    Goenka A; Magsanoc JM; Pei X; Schechter M; Kollmeier M; Cox B; Scardino PT; Eastham JA; Zelefsky MJ
    Eur Urol; 2011 Dec; 60(6):1142-8. PubMed ID: 21855208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of survival rates between 3D conformal radiotherapy and intensity-modulated radiotherapy in patients with stage III non-small cell lung cancer.
    Kong M; Hong SE
    Onco Targets Ther; 2016; 9():7227-7234. PubMed ID: 27920560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of intensity-modulated radiotherapy versus conventional radiotherapy for hypopharyngeal cancer.
    Mok G; Gauthier I; Jiang H; Huang SH; Chan K; Witterick IJ; O'Sullivan B; Waldron JN; Bayley AJ; Cho BC; Cummings BJ; Dawson LA; Hope AJ; Kim JJ; Ringash J
    Head Neck; 2015 May; 37(5):655-61. PubMed ID: 24590756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.